Clinical trial
Safety and Effectiveness of Zintevir (AR177) Given to HIV-Infected Patients
NCT00002403 · Aronex Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00002403 |
|---|---|
| Title | Safety and Effectiveness of Zintevir (AR177) Given to HIV-Infected Patients |
| Official title | A Phase I/II Multiple Dose Study to Evaluate the Safety, Pharmacokinetic Profile and Virologic/Immunologic Activity of Zintevir (AR177) in HIV-1 Patients |
| Lead sponsor | Aronex Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Drug |
| Interventions | Zintevir |
| Enrollment | 12 |
| First posted | Aug 31, 2001 |
| Last update posted | Jun 24, 2005 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: